Atlas Trials

The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD

Clinical trial NCT01860482 · COMPLETED

Trial details

NCT number
NCT01860482
Sponsor
Chong Kun Dang Pharmaceutical
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Reflux Esophagitis
Start date
2013-04-01
Primary completion
2015-05-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.